These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 28841854)

  • 1. Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine.
    Medeiros MIC; Almeida SCG; Guerra MLLS; da Silva P; Carneiro AMM; de Andrade D
    BMC Infect Dis; 2017 Aug; 17(1):590. PubMed ID: 28841854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.
    Brandileone MC; Zanella RC; Almeida SCG; Brandao AP; Ribeiro AF; Carvalhanas TMP; Sato H; Andrade AL; Verani JR;
    Vaccine; 2016 Nov; 34(46):5604-5611. PubMed ID: 27692770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
    Brandileone MC; Almeida SCG; Minamisava R; Andrade AL
    Vaccine; 2018 May; 36(19):2559-2566. PubMed ID: 29650385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.
    Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N
    Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern Mozambique.
    Massora S; Lessa FC; Moiane B; Pimenta FC; Mucavele H; Chaúque A; Cossa A; Verani JR; Tembe N; da Gloria Carvalho M; Muñoz-Almagro C; Sigaúque B
    Vaccine; 2019 Dec; 37(51):7470-7477. PubMed ID: 31575493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
    Motlová J
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014.
    Nackers F; Cohuet S; le Polain de Waroux O; Langendorf C; Nyehangane D; Ndazima D; Nanjebe D; Karani A; Tumwesigye E; Mwanga-Amumpaire J; Scott JAG; Grais RF
    Vaccine; 2017 Sep; 35(39):5271-5277. PubMed ID: 28784282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microbiological implications of invasive pneumococcal disease in hospitalized patients (1998-2013).
    Medeiros MI; Negrini BV; Silva JM; Almeida SC; Leopoldo ML; Leopoldo Silva Guerra ML; Guerra S; Andrade Dd
    Braz J Infect Dis; 2016; 20(3):242-9. PubMed ID: 27094236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
    Zhao C; Li Z; Zhang F; Zhang X; Ji P; Zeng J; Hu B; Hu Z; Liao K; Sun H; Zhang R; Cao B; Zhuo C; Jia W; Mei Y; Chu Y; Xu X; Yang Q; Jin Y; Fu Q; Xu X; Li H; Wang L; Ni Y; Liang H; Wang H
    BMC Infect Dis; 2017 Dec; 17(1):804. PubMed ID: 29284419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine.
    Payeras A; Villoslada A; Garau M; Salvador MN; Gallegos MC
    Int J Infect Dis; 2015 Apr; 33():22-7. PubMed ID: 25541296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).
    Horácio AN; Silva-Costa C; Lopes E; Ramirez M; Melo-Cristino J;
    PLoS One; 2018; 13(11):e0206912. PubMed ID: 30388168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil.
    Mott M; Caierão J; Rosa da Cunha G; Rodrigues Perez LR; Matusiak R; Pilger de Oliveira KR; d'Azevedo PA; Dias C
    Int J Infect Dis; 2014 Mar; 20():47-51. PubMed ID: 24389158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed.
    Lyu S; Hu HL; Yang YH; Yao KH
    Expert Rev Vaccines; 2017 Oct; 16(10):997-1006. PubMed ID: 28745918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil.
    Brandileone MC; Zanella RC; Almeida SCG; Cassiolato AP; Lemos APS; Salgado MM; Higa FT; Minamisava R; Andrade AL
    Vaccine; 2019 Aug; 37(36):5357-5363. PubMed ID: 31351796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus pneumoniae Serotypes Identified in Mexican Children with Invasive Disease Before and After the Introduction of PCV7 (1993-2012).
    Echaniz-Aviles G; Soto-Nogueron A; Miranda-Novales G; Carnalla-Barajas MN; Velazquez-Meza ME; Solórzano-Santos F;
    Arch Med Res; 2015 Feb; 46(2):149-53. PubMed ID: 25743930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.